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Background
Mupirocin nasal ointment, together with chlorhexidine-based skin disinfectants, have been used for methicillin resistant Staphylococcus aureus (MRSA) decolonization, but emergence of resistance strains highlights the need for alternative strategies. In the present study, we investigated the bactericidal activity of octenidine among international epidemic clones of S. aureus, including mupirocin resistant strains. Materials and methods Eight S. aureus isolates belonging to different epidemic clones were included. Mupirocin resistance was tested by disk diffusion, E-test and by PCR amplification of mupA and mupB. The bactericidal efficacy of octenidine was determined with and without organic load (albumin) by quantitative suspension tests according to EN13727. Results Two MRSA isolates showed high-level mupirocin resistance (MIC > 1024 mg/L and mupA), two MRSA isolates showed lowlevel mupirocin resistance (MICs = 24 and 32 mg/L) and the two remaining MRSA and the two MSSA were susceptible to mupirocin (MICs = 0.25 to 0.75 mg/L). Octenidine was effective (bacterial reduction more than 6 log10) at a concentration of 0.001% (10 ppm) after 30 seconds of contact time for all isolates tested. With 0.6% albumin (corresponding to protein levels found in human nasal mucosa), bacterial reduction more than 6 log10 was observed with 0.01% Background Multidrug-resistant gram-negative (MRGN) pathogens pose a major and growing threat for health care systems, as therapy of infections is often limited due to the lack of available systemic antibiotics. Well tolerated antiseptic molecules may be a very useful implementation in infection control,not only to reduce the dissemination of methicillin-resistant Staphylococcus aureus (MRSA), but also MRGN.
Material and methods
As decolonization strategies with regard to MRSA are already implemented in high risk areas (i.e. ICUs), this study aimed to investigate, if the same protocol might be concomitantly efficient against MRGN. A series of 5 different species (Escherichia coli, Klebsiella pneumoniae, Enterobacter cloacae, Acinetobacter baumannii, Pseudomonas aeruginosa) was studied to prove efficacy under clinically relevant conditions according to an official test norm (EN13727). We used 5 clonally-unrelated isolates per species, including a single wild-type strain, and four MRGN isolates, corresponding either to the 3 MRGN or 4 MRGN definition of multidrug resistance. Octenidine (OCT, Schuelke&Mayr GmbH, Germany) susceptibility was evaluated with and without organic load. Results A contact time of 30 seconds or 1 minute was fully effective for all isolates by using different OCT concentrations (0.01% and 0.05%), with a bacterial reduction factor of >5 log systematically observed. Growth kinetics were determined with two different wild-type strains (A. baumannii and K. pneumoniae), proving a time-dependent efficacy of OCT, mirroring what has been previously observed for MRSA. Conclusions These results highlight that OCT, besides being a very effective agent against MRSA, may also be extremely useful to eradicate emerging highly resistant gram-negative pathogens associated with nosocomial infections. Background Acinetobacter baumannii is an important opportunistic nosocomial pathogen causing a variety of infections. The intrinsic virulence of drug-resistant A. baumannii has remained controversial. We compared mortality rates and sepsis score of patients with A. baumannii bacteremia caused by different level of drug resistance. Materials and methods A retrospective study was conducted in adult patients (age > 15 years) admitted to Songklanagarind hospital during 2009 and 2015 and blood culture positive for A. baumannii after 3 days of admission. Antimicrobial resistance was categorized into four levels comprising of non-multidrug resistance (non-MDR), multidrug-resistant (MDR), extensively drug-resistant (XDR), and possible pandrug-resistant (possible-PDR). Severity of underlying disease of the patients immediately before onset of bacteremia was determined by sequential organ failure (SOFA) score and American Association of Anesthesia (ASA) score. Virulence of A. baumannii was assessed in terms of sepsis score and in hospital mortality rate.
Results
The study identified 38, 110, 168, and 14 cases of bacteremia caused by non-MDR, MDR, XDR, and possible PDR, respectively. After adjusting for confounding effect by using Cox proportional hazard model, mortality rates attributable to A. baumannii was significantly associated to levels of drug resistance. Using nonMDR as a reference, the incidence rate ratios and corresponding 95% confidence intervals (95% CI) of MDR, XDR, and possible PDR were 2.3 (95% CI = 0.9-4.9), 3.1(95% CI = 1.4-7.0), and 1.9(95% CI = 0.6-5.5) respectively. 
Conclusions
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The influence of disease burden for patients infected with multidrug-resistant pathogens Ming-Chin Chan 1 , Chih-Chien Wang
Background
Since the use of antibiotics, drug-resistant pathogens were inevitably appeared. It is undoubtedly a huge challenge to clinical practices. Infections with multidrug-resistant pathogens would result in higher mortality rate and extra medical expenses.
Materials and methods
This research collected and analyzed healthcare-associated bloodstream infection by multi-drug resistant pathogens including Acinetobacter baumannii, Pseudomonas aeruginosa, vancomycin-resistant enterococci (VRE), Staphylococcus aureus and E. coli in Tri-Service General Hospital between 2011 and 2014. The cases were collected by infection control nurses. All the information and the expenditure of ICUs or wards were analyzed and compared.
Results
The results showed the highest mortality was VRE, about 80% and 57% of mortality rate in ICUs and wards, respectively. The longest days from admission to infection was Staphylococcus aureus, about 55.4 and 74.5 days in ICU and ward, respectively. Moreover, pathogen that has the longest days from infection to outpatient or expired was E. coli, with the average of 59.6 and 41.6 days in ICUs and wards, respectively. As for the expenditure, patients infected with E. coli in ICUs, and patients infected with VRE in wards cost the most expenses, which was about 15,333 and 5,000 US dollars, respectively.
Conclusions
The expenditure for nosocomial infections with multi-drug resistant pathogens in ICUs is higher than in wards, especially infected with E. coli, the other four pathogens caused about 6,333-10,000 US dollars in ICUs. In wards, it is about 3,667-4,667 US dollars infected with VRE, Staphylococcus aureus and E. coli. The antibiotics cost is the highest when infected with VRE. Background Surgical site infection (SSI) is the most common hospital acquired infection at obstetrics and gynecology hospital. SSI prolonged hospital stay and increased treatment costs. We aimed to identify incidence and causative organism of surgical site infection among cesarean section and gynecology surgery cases. Materials and methods A prospective cohort study was conducted at Hung Vuong Hospital, Viet Nam from January 2015 to May 2016. Women who underwent caesarean and gynecological surgery were included in the study. CDC criteria (2009) were used to diagnose SSI. Results 29,681 women underwent caesarean and gynecological surgery. SSI rate was 1.1% (95% CI: 0.98 -1.22%), in which 0.96% SSI after caesarean section (95% CI: 0.84 -1.08%) and 1.7% SSI after gynecological surgery (6.26% SSI after hysterectomy with 95% CI: 4.91 -7.79%). Average number of treatment days that with SSI is 9 ± 4.5 days. Staphylococcus aureus and coagulase-negative staphylococci were the most common organism caused SSI after caesarean section (50%) and Escherichia coli was the main organism for SSI after gynecology operation (66.7%).
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Conclusions
The incidence of SSIs was limited because we only follow patients with SSIs who were treated in hospital. The incidence of SSIs after hysterectomy surgery was higher than other types of gynecologic surgery. It's necessary to promote infection control to reduce SSI in hysterectomy surgery.
